The estimated Net Worth of Yuhang Zhao is at least $3.36 mil dollars as of 20 August 2021. Yuhang Zhao owns over 12,000 units of OncoSec Medical Inc stock worth over $3,360 and over the last 4 years he sold ONCS stock worth over $0. In addition, he makes $0 as Director at OncoSec Medical Inc.
Yuhang has made over 1 trades of the OncoSec Medical Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he bought 12,000 units of ONCS stock worth $23,040 on 20 August 2021.
The largest trade he's ever made was buying 12,000 units of OncoSec Medical Inc stock on 20 August 2021 worth over $23,040. On average, Yuhang trades about 4,000 units every 0 days since 2020. As of 20 August 2021 he still owns at least 12,000 units of OncoSec Medical Inc stock.
You can see the complete history of Yuhang Zhao stock trades at the bottom of the page.
Dr. Yuhang Zhao serves as Director of the Company. Dr. Yuhang Zhao, a graduate from Peking University, received her Doctorate in Molecular Biology from Rockefeller University and her MBA in Finance from NYU Stern Business School. Dr. Zhao was most recently a member of the Bayer Global Leadership Circle. She established one of Bayer’s four Global Clinical Development sites, located in Beijing, China in 2009. She then became Head of Global Strategy for Bayer Consumer Health, reporting to the President. Prior to her positions in the pharmaceutical industry, Dr. Zhao held positions as a stock analyst at PaineWebber and was a management consultant specializing in strategies for life science companies). Dr. Zhao currently serves on the board of R2 Technologies and is a senior adviser to China Grand Enterprises.
Yuhang Zhao is 55, he's been the Director of OncoSec Medical Inc since 2020. There are 4 older and 6 younger executives at OncoSec Medical Inc. The oldest executive at OncoSec Medical Inc is Margaret Dalesandro, 73, who is the Independent Chairman of the Board.
Yuhang's mailing address filed with the SEC is 24, North Main Street, Pennington, Mercer County, New Jersey, 08534, United States of America.
Over the last 12 years, insiders at OncoSec Medical Inc have traded over $1,474,366 worth of OncoSec Medical Inc stock and bought 9,275,650 units worth $39,853,210 . The most active insiders traders include Grand Pharmaceutical & Heal..., Holdings, Inc. Alpha, eRobert Ward. On average, OncoSec Medical Inc executives and independent directors trade stock every 62 days with the average trade being worth of $51,563. The most recent stock trade was executed by Robert J Del Aversano on 9 February 2023, trading 40 units of ONCS stock currently worth $55.
oncosec is a san diego-based biotechnology company pioneering new technologies to stimulate the body’s immune system to target and attack cancer. through our proprietary technology, we hope to deliver safer and more effective cancer treatments that can provide long-term benefits for patients. our technology, immunopulse™, is designed to enhance the local delivery and uptake of dna-based immune-targeting agents, such as il-12. clinical trials of immunopulse™ il-12 demonstrated a favorable safety profile and evidence of anti-tumor activity in the treatment of various skin cancers as well as the potential to initiate a systemic immune response. our lead program, immunopulse™ il-12, is currently in phase ii development for several indications, including metastatic melanoma, squamous cell carcinoma of the head and neck, and triple-negative breast cancer. to date, study results have laid the groundwork for the expansion into new dna-encoded therapeutic candidates and tumor indications. we ar
OncoSec Medical Inc executives and other stock owners filed with the SEC include: